Charanjit Aulakh

Array ( [id] => 5527829 [patent_doc_number] => 20090197906 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-08-06 [patent_title] => 'REVERSION OF MALIGNANT PHENOTYPE WITH 9-HYDROXY ELLIPTICINE DERIVATIVES' [patent_app_type] => utility [patent_app_number] => 12/301534 [patent_app_country] => US [patent_app_date] => 2007-05-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 8833 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0197/20090197906.pdf [firstpage_image] =>[orig_patent_app_number] => 12301534 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5259730 [patent_doc_number] => 20070213362 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-09-13 [patent_title] => '2-NH-HETEROARYLIMIDAZOLES WITH ANTIBACTERIAL ACTIVITY' [patent_app_type] => utility [patent_app_number] => 11/751451 [patent_app_country] => US [patent_app_date] => 2007-05-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15340 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0213/20070213362.pdf [firstpage_image] =>[orig_patent_app_number] => 11751451 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 53695 [patent_doc_number] => 07772431 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2010-08-10 [patent_title] => 'Performance of energy storage devices: potential areas for dendritic chemistry involvement' [patent_app_type] => utility [patent_app_number] => 11/750448 [patent_app_country] => US [patent_app_date] => 2007-05-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 14 [patent_no_of_words] => 8808 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/772/07772431.pdf [firstpage_image] =>[orig_patent_app_number] => 11750448 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4451038 [patent_doc_number] => 07964361 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-06-21 [patent_title] => 'Rigidized trimethine cyanine dyes' [patent_app_type] => utility [patent_app_number] => 11/798549 [patent_app_country] => US [patent_app_date] => 2007-05-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 15247 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 66 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/964/07964361.pdf [firstpage_image] =>[orig_patent_app_number] => 11798549 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4681738 [patent_doc_number] => 20080247964 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-10-09 [patent_title] => 'SUBSTITUTED AZASPIRO DERIVATIVES' [patent_app_type] => utility [patent_app_number] => 11/745448 [patent_app_country] => US [patent_app_date] => 2007-05-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 36490 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0247/20080247964.pdf [firstpage_image] =>[orig_patent_app_number] => 11745448 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4960815 [patent_doc_number] => 20080275240 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-11-06 [patent_title] => 'New and efficient process for the preperation of cabergoline and its intermediates' [patent_app_type] => utility [patent_app_number] => 11/797510 [patent_app_country] => US [patent_app_date] => 2007-05-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4820 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0275/20080275240.pdf [firstpage_image] =>[orig_patent_app_number] => 11797510 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4515993 [patent_doc_number] => 07910736 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-03-22 [patent_title] => 'Method for producing organic field-effect transistors' [patent_app_type] => utility [patent_app_number] => 11/744611 [patent_app_country] => US [patent_app_date] => 2007-05-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 8 [patent_no_of_words] => 15808 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 12 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/910/07910736.pdf [firstpage_image] =>[orig_patent_app_number] => 11744611 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6137619 [patent_doc_number] => 20110009634 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-01-13 [patent_title] => 'PROCESS FOR PREPARING OXYMORPHONE' [patent_app_type] => utility [patent_app_number] => 12/446171 [patent_app_country] => US [patent_app_date] => 2007-05-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2579 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0009/20110009634.pdf [firstpage_image] =>[orig_patent_app_number] => 12446171 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5005593 [patent_doc_number] => 20070203165 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-08-30 [patent_title] => 'COMPOUNDS AND METHODS FOR LOWERING THE ABUSE POTENTIAL AND EXTENDING THE DURATION OF ACTION OF A DRUG' [patent_app_type] => utility [patent_app_number] => 11/742566 [patent_app_country] => US [patent_app_date] => 2007-04-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8455 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0203/20070203165.pdf [firstpage_image] =>[orig_patent_app_number] => 11742566 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 341677 [patent_doc_number] => 07501435 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-03-10 [patent_title] => 'Inhibitors of checkpoint kinases' [patent_app_type] => utility [patent_app_number] => 11/789288 [patent_app_country] => US [patent_app_date] => 2007-04-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 36757 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/501/07501435.pdf [firstpage_image] =>[orig_patent_app_number] => 11789288 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 820634 [patent_doc_number] => 07407967 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-08-05 [patent_title] => 'Cyclopamine analogues and methods of use thereof' [patent_app_type] => utility [patent_app_number] => 11/737035 [patent_app_country] => US [patent_app_date] => 2007-04-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 23060 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/407/07407967.pdf [firstpage_image] =>[orig_patent_app_number] => 11737035 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5211069 [patent_doc_number] => 20070249653 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-10-25 [patent_title] => 'Tetracyclic benzamide derivatives and methods of use thereof' [patent_app_type] => utility [patent_app_number] => 11/786627 [patent_app_country] => US [patent_app_date] => 2007-04-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 32772 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 16 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0249/20070249653.pdf [firstpage_image] =>[orig_patent_app_number] => 11786627 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 345153 [patent_doc_number] => 07498340 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-03-03 [patent_title] => 'Esters in position 20 of camptothecins' [patent_app_type] => utility [patent_app_number] => 11/783495 [patent_app_country] => US [patent_app_date] => 2007-04-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8625 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/498/07498340.pdf [firstpage_image] =>[orig_patent_app_number] => 11783495 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4867743 [patent_doc_number] => 20080146802 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-06-19 [patent_title] => 'Organic memory device using iridium organometallic compound and fabrication method thereof' [patent_app_type] => utility [patent_app_number] => 11/783138 [patent_app_country] => US [patent_app_date] => 2007-04-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 6589 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0146/20080146802.pdf [firstpage_image] =>[orig_patent_app_number] => 11783138 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8909672 [patent_doc_number] => 08481736 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-07-09 [patent_title] => 'Liquid crystalline rylene tetracarboxylic acid derivatives and use thereof' [patent_app_type] => utility [patent_app_number] => 12/296312 [patent_app_country] => US [patent_app_date] => 2007-04-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 14 [patent_no_of_words] => 34534 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12296312 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4609509 [patent_doc_number] => 07994187 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-08-09 [patent_title] => 'HIV inhibiting 3,4-dihydro-imidazo[4,5-B]pyridin-5-ones' [patent_app_type] => utility [patent_app_number] => 12/295816 [patent_app_country] => US [patent_app_date] => 2007-04-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 21498 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/994/07994187.pdf [firstpage_image] =>[orig_patent_app_number] => 12295816 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 159452 [patent_doc_number] => 07674800 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-03-09 [patent_title] => 'Oxycodone hydrochloride having less than 25 PPM 14-hydroxycodeinone' [patent_app_type] => utility [patent_app_number] => 11/729741 [patent_app_country] => US [patent_app_date] => 2007-03-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 17705 [patent_no_of_claims] => 81 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 94 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/674/07674800.pdf [firstpage_image] =>[orig_patent_app_number] => 11729741 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5189172 [patent_doc_number] => 20070167481 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-07-19 [patent_title] => 'IMIDAZONAPHTHYRIDINES' [patent_app_type] => utility [patent_app_number] => 11/692701 [patent_app_country] => US [patent_app_date] => 2007-03-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 42907 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0167/20070167481.pdf [firstpage_image] =>[orig_patent_app_number] => 11692701 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6569056 [patent_doc_number] => 20100234412 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-09-16 [patent_title] => 'Buprenorphine Derivatives and Uses Thereof' [patent_app_type] => utility [patent_app_number] => 12/294462 [patent_app_country] => US [patent_app_date] => 2007-03-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 9856 [patent_no_of_claims] => 40 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0234/20100234412.pdf [firstpage_image] =>[orig_patent_app_number] => 12294462 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 311101 [patent_doc_number] => 07528125 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-05-05 [patent_title] => 'Water-soluble zinc ionophores, zinc chelators, and/or zinc complexes and use for treating cancer' [patent_app_type] => utility [patent_app_number] => 11/688789 [patent_app_country] => US [patent_app_date] => 2007-03-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 51 [patent_figures_cnt] => 51 [patent_no_of_words] => 46566 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/528/07528125.pdf [firstpage_image] =>[orig_patent_app_number] => 11688789 [rel_patent_id] =>[rel_patent_doc_number] =>)